脂蛋白相关磷脂酶A2活性与糖尿病视网膜病变风险增加相关:一项纵向疾病进展研究
基于GoDARTS队列中1364例2型糖尿病参与者,采用竞争风险生存分析,按Lp-PLA2活性四分位数分层,随访3年。研究发现Lp-PLA2活性最高四分位组发生糖尿病视网膜病变的风险是最低四分位组的2.08倍(95%CI 1.64,2.63),且与向更严重分级转变的风险增加相关,该关联独立于计算LDL胆固醇及其他传统危险因素。
要点
- Lp-PLA2活性最高四分位组发生糖尿病视网膜病变的风险是最低四分位组的2.08倍(95%CI 1.64,2.63)。
- Lp-PLA2活性最高四分位组发生可观察(或更严重)视网膜病变的风险是最低四分位组的2.82倍(95%CI 1.71,4.65)。
- Lp-PLA2活性最高四分位组发生需转诊(或更严重)视网膜病变的风险是最低四分位组的1.87倍(95%CI 1.26,2.77)。
核心结论
- 较高的Lp-PLA2水平与死亡风险增加、新发糖尿病视网膜病变风险增加以及向更严重糖尿病视网膜病变分级转变相关。
- 这些关联独立于计算LDL胆固醇和其他传统危险因素。
- 该生物标志物研究表明,这种关联在时间上对事件与Lp-PLA2测量之间的接近程度敏感。
研究设计与样本
- 本研究为队列研究,使用GoDARTS(苏格兰泰赛德糖尿病审计与研究遗传学)队列中具有基线血清和常规收集的糖尿病视网膜筛查数据的2型糖尿病参与者。
- 该队列由来自苏格兰泰赛德地区的白色苏格兰血统个体组成。
- 采用竞争风险生存分析(将死亡建模为竞争风险以处理信息性删失),在3年随访期内(n=1364)按Lp-PLA2活性四分位数分层,分析从无病状态新发糖尿病视网膜病变的情况。
- 对向更严重分级转变的情况进行了相同的分析。
主要发现
- Lp-PLA2活性最高四分位组发生新发糖尿病视网膜病变的风险是最低四分位组的2.08倍(95%CI 1.64,2.63)。
- 较高的Lp-PLA2活性水平与向所有分级转变的风险显著增加相关。
- Lp-PLA2活性最高四分位组发生可观察(或更严重)视网膜病变和需转诊(或更严重)视网膜病变的风险分别是最低四分位组的2.82倍(95%CI 1.71,4.65)和1.87倍(95%CI 1.26,2.77)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A2 (Lp-PLA2) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3 year follow-up period (n = 1364) by stratified Lp-PLA2 activity levels (in quartiles). The same analysis was performed for transitions to more severe grades. RESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA2 activity compared with the lowest. Higher Lp-PLA2 activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA2 activity compared with the lowest, respectively. CONCLUSIONS/INTERPRETATION: Higher Lp-PLA2 levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA2.
引用
- Siddiqui MK, Kennedy G, Carr F, et al. Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study. Diabetologia. 2018. PMID: 29623345. doi:10.1007/s00125-018-4601-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。